Corn PG - Search Results

1

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

Labanca E, Yang J, Shepherd PDA, Wan X, Starbuck MW, Guerra LD, Anselmino N, Bizzotto JA, Dong J, Chinnaiyan AM, Ravoori MK, Kundra V, Broom BM, Corn PG, Troncoso P, Gueron G, Logothethis CJ, Navone NM. Labanca E, et al. Among authors: corn pg. Eur Urol Oncol. 2022 Apr;5(2):164-175. doi: 10.1016/j.euo.2021.10.001. Epub 2021 Nov 11. Eur Urol Oncol. 2022. PMID: 34774481 Free article.

2

Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.

Araujo JC, Poblenz A, Corn P, Parikh NU, Starbuck MW, Thompson JT, Lee F, Logothetis CJ, Darnay BG. Araujo JC, et al. Cancer Biol Ther. 2009 Nov;8(22):2153-9. doi: 10.4161/cbt.8.22.9770. Epub 2009 Nov 8. Cancer Biol Ther. 2009. PMID: 19855158 Free PMC article.

3

Novel therapies for metastatic castrate-resistant prostate cancer.

Dayyani F, Gallick GE, Logothetis CJ, Corn PG. Dayyani F, et al. Among authors: corn pg. J Natl Cancer Inst. 2011 Nov 16;103(22):1665-75. doi: 10.1093/jnci/djr362. Epub 2011 Sep 13. J Natl Cancer Inst. 2011. PMID: 21917607 Free PMC article. Review.

4

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.

Varkaris A, Corn PG, Gaur S, Dayyani F, Logothetis CJ, Gallick GE. Varkaris A, et al. Among authors: corn pg. Expert Opin Investig Drugs. 2011 Dec;20(12):1677-84. doi: 10.1517/13543784.2011.631523. Epub 2011 Oct 28. Expert Opin Investig Drugs. 2011. PMID: 22035268 Free PMC article. Review.

5

Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Gallick GE, Corn PG, Zurita AJ, Lin SH. Gallick GE, et al. Among authors: corn pg. Future Med Chem. 2012 Jan;4(1):107-19. doi: 10.4155/fmc.11.161. Future Med Chem. 2012. PMID: 22168167 Free PMC article.

6

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials.

Som A, Tu SM, Liu J, Wang X, Qiao W, Logothetis C, Corn PG. Som A, et al. Among authors: corn pg. Br J Cancer. 2012 Oct 23;107(9):1547-53. doi: 10.1038/bjc.2012.436. Epub 2012 Oct 2. Br J Cancer. 2012. PMID: 23033003 Free PMC article.

7

Optimal therapy sequencing in metastatic castration-resistant prostate cancer.

Abouharb S, Corn PG. Abouharb S, et al. Among authors: corn pg. Curr Oncol Rep. 2013 Jun;15(3):217-23. doi: 10.1007/s11912-013-0311-y. Curr Oncol Rep. 2013. PMID: 23568599 Review.

8

Platinum-based chemotherapy for variant castrate-resistant prostate cancer.

Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Aparicio AM, et al. Among authors: corn pg. Clin Cancer Res. 2013 Jul 1;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12-3791. Epub 2013 May 6. Clin Cancer Res. 2013. PMID: 23649003 Free PMC article.

9

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

Karantanos T, Corn PG, Thompson TC. Karantanos T, et al. Among authors: corn pg. Oncogene. 2013 Dec 5;32(49):5501-11. doi: 10.1038/onc.2013.206. Epub 2013 Jun 10. Oncogene. 2013. PMID: 23752182 Free PMC article. Review.

10

Targeting fibroblast growth factor pathways in prostate cancer.

Corn PG, Wang F, McKeehan WL, Navone N. Corn PG, et al. Clin Cancer Res. 2013 Nov 1;19(21):5856-66. doi: 10.1158/1078-0432.CCR-13-1550. Epub 2013 Sep 19. Clin Cancer Res. 2013. PMID: 24052019 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters